IRIS UniCatt

Barone, Carlo Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.641
EU - Europa 3.457
AS - Asia 2.625
SA - Sud America 446
AF - Africa 89
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 10.271
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.547
DE - Germania 1.490
SG - Singapore 1.191
CN - Cina 627
SE - Svezia 428
BR - Brasile 361
IT - Italia 289
VN - Vietnam 265
PL - Polonia 239
FR - Francia 201
GB - Regno Unito 183
UA - Ucraina 182
IN - India 117
IE - Irlanda 106
FI - Finlandia 85
RU - Federazione Russa 74
ID - Indonesia 73
JP - Giappone 64
HK - Hong Kong 52
TR - Turchia 50
CA - Canada 46
NL - Olanda 34
AR - Argentina 33
BD - Bangladesh 33
BE - Belgio 33
MX - Messico 32
IQ - Iraq 29
ZA - Sudafrica 28
ES - Italia 26
CI - Costa d'Avorio 22
EC - Ecuador 21
IR - Iran 21
SA - Arabia Saudita 16
AT - Austria 15
KR - Corea 14
LT - Lituania 14
RO - Romania 12
MA - Marocco 10
PK - Pakistan 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
AU - Australia 7
CO - Colombia 7
CZ - Repubblica Ceca 7
JO - Giordania 7
PH - Filippine 7
RS - Serbia 7
VE - Venezuela 7
CL - Cile 6
KE - Kenya 6
SN - Senegal 5
CH - Svizzera 4
GE - Georgia 4
MD - Moldavia 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
EU - Europa 3
IL - Israele 3
JM - Giamaica 3
LB - Libano 3
ML - Mali 3
OM - Oman 3
PS - Palestinian Territory 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
EG - Egitto 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
QA - Qatar 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
Totale 10.260
Salva come PNG Salva come JPEG
Città #
Singapore 693
Chandler 476
Ashburn 341
San Jose 320
Warsaw 218
Ann Arbor 123
Jacksonville 114
Beijing 111
Dublin 104
New York 98
San Mateo 97
Nürnberg 89
Nanjing 85
Wilmington 85
Los Angeles 84
Cattolica 82
Ho Chi Minh City 77
Lauterbourg 65
Hanoi 63
Jakarta 62
Chicago 60
Boston 58
Tokyo 55
Dearborn 54
Dallas 53
Munich 46
Houston 45
Frankfurt am Main 44
Hong Kong 43
Fairfield 42
Rome 41
Moscow 40
Woodbridge 40
Nanchang 36
Hangzhou 34
Lawrence 34
Milan 34
Brussels 33
Redmond 33
Helsinki 32
Redwood City 31
São Paulo 31
Seattle 28
Shanghai 28
Hefei 27
Izmir 27
Marseille 27
Princeton 25
Santa Clara 25
Abidjan 22
Orem 22
Boardman 21
Falls Church 20
Mountain View 20
San Francisco 19
Buffalo 18
Council Bluffs 18
Guangzhou 18
London 18
Cambridge 17
Can Tho 17
Hebei 17
Brooklyn 16
Johannesburg 16
Paris 16
Bremen 15
Shenyang 15
Atlanta 14
Hyderabad 14
Leawood 14
The Dalles 14
Amsterdam 13
Changsha 13
Denver 13
Kraków 13
Norwalk 13
Montreal 12
Phoenix 12
Poplar 12
Chennai 11
Da Nang 11
Fremont 11
Kent 11
Kunming 11
Manchester 11
Toronto 11
Augusta 10
Lancaster 10
Rio de Janeiro 10
University Park 10
Ankara 9
Detroit 9
Erbil 9
Mumbai 9
Nuremberg 9
Quito 9
Tashkent 9
Baghdad 8
Belo Horizonte 8
Dhaka 8
Totale 5.179
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 408
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 351
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 320
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 307
A phase II study of sunitinib in advanced hepatocellular carcinoma 270
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 269
KRAS Early Testing: Consensus Iniziative and Cost-Effectiveness Evaluation for metastatic colerectal patiens in an Italian Setting 260
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 234
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 227
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 208
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 194
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 190
Treatment options of simple bone cysts: the role of bone substitutes, growth factors and literature review 183
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 183
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 182
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 181
Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer 171
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 160
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 158
Are TKIs favourable for the elderly with non-small-cell lung cancer? 158
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 157
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 156
Use of trastuzumab in HER2-positive metastatic breast cancer beyond disease progression: a systematic review of published studies 155
AMAROS Study: Overall Survival in Breast Cancer Subtypes 154
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 148
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 147
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 146
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies 146
The immune response to tumors as a tool toward immunotherapy 144
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 141
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 140
Advanced colon cancer: staging and prognosis by CEA test 137
Gas in portal circulation and pneumatosis cystoides intestinalis during chemotherapy for advanced rectal cancer 137
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 136
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 135
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial 134
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 133
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 131
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 130
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 128
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 127
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 125
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 123
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 120
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 116
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 112
Indications for prophylactic osteosynthesis associated with curettage in benign and low-grade malignant primitive bone tumors of the distal femur in adult patients: a case series 111
Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score 103
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 103
LUX-Lung 7: is there enough data for a final conclusion? 100
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 100
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 98
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 94
Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase II study 90
Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis 89
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 88
Randomised, placebo-controlled, double-blind, parallele-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer 87
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 84
The interference between oxaliplatin & anti-EGFR therapies: A different hypothesis to explain the 'unexplainable' 84
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 82
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 76
Soft tissue metastases in lung cancer: a review of the literature 76
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC 76
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations 75
Multidisciplinary approach for HCC patients: hepatology for the oncologists 73
Targeted therapy in advanced gastric carcinoma: The future is beginning 73
New life for retrospective study in the precision oncology era 67
Lung adenocarcinoma presenting as a solitary gingival metastasis: a case report 61
Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line 46
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy 43
QUALITY OF LIFE FOLLOWING SURGICAL TREATMENT OF LOWER LIMB METASTASES IN LONG BONE 4
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis 1
Totale 10.392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 0 69 17
2021/2022704 54 44 19 79 49 29 16 108 37 49 80 140
2022/20231.267 182 179 106 226 54 158 64 103 118 25 41 11
2023/2024542 24 162 21 18 15 82 33 42 5 15 51 74
2024/20251.099 25 52 90 53 95 44 47 50 128 111 188 216
2025/20263.422 495 87 200 462 670 168 623 171 230 197 119 0
Totale 10.392